Vertebrate TFPI-2 C-terminal peptides exert therapeutic applications against Gram-negative infections.
Gopinath KasettyEmanuel SmedsEmelie HolmbergLouise WrangeSelvi AdikesavanPraveen PapareddyPublished in: BMC microbiology (2016)
Our results suggest that the evolutionary conserved C-terminal part of TFPI-2 is an interesting agent for the development of novel antimicrobial therapies.